{"access":{"can_view":true,"can_edit":false,"can_remove":false,"can_add":false,"can_publish":false,"can_get_doi":false,"can_share":true,"can_move":true,"can_move_outside":true,"can_transfer":true,"can_download":true,"is_locked":false},"authors":[{"name":"Hankum Park","affiliation":"Department of Cell Biology, Harvard Medical School Boston, MA 02115, USA; Aligning Science Across Parkinson's (ASAP) Collaborative Research Network, Chevy Chase, MD 20815, USA; Current affiliation: Seoul National University, School of Dentistry","affiliation_url":null,"username":"","link":null,"image":{"source":"","placeholder":"","webp_source":""},"note":"","is_verified_author":true,"is_verified_user":false},{"name":"Frances V Hundley","affiliation":"Department of Cell Biology, Harvard Medical School Boston, MA 02115, USA; Aligning Science Across Parkinson's (ASAP) Collaborative Research Network, Chevy Chase, MD 20815, USA","affiliation_url":null,"username":"frances-hundley","link":"","image":{"source":"/img/avatars/010.png","placeholder":"/img/avatars/010.png","webp_source":""},"note":"","is_verified_author":true,"is_verified_user":true},{"name":"Sharan Sharan Swarup","affiliation":"Harvard Medical School","affiliation_url":"","username":"sharan-swarup","link":"","image":{"source":"/img/avatars/008.png","placeholder":"/img/avatars/008.png","webp_source":""},"note":"","is_verified_author":true,"is_verified_user":true},{"name":"Harper     JW","affiliation":"Department of Cell Biology, Harvard Medical School Boston, MA 02115, USA; Aligning Science Across Parkinson's (ASAP) Collaborative Research Network, Chevy Chase, MD 20815, USA","affiliation_url":null,"username":"harper----jw","link":null,"image":{"source":"/img/avatars/016.png","placeholder":"/img/avatars/016.png","webp_source":""},"note":"","is_verified_author":true,"is_verified_user":true}],"before_start":"","book_chapter":null,"can_accept_authorship":false,"can_be_copied":true,"can_claim_authorship":false,"can_remove_fork":false,"can_sign":false,"child_steps":{},"cited_protocols":[],"collection_items":[],"created_on":1648229936,"creator":{"name":"Frances Hundley","affiliation":"","affiliation_url":null,"username":"frances-hundley","link":"","image":{"source":"/img/avatars/010.png","placeholder":"/img/avatars/010.png","webp_source":""},"badges":[{"id":3,"name":"Power author!","image":{"source":"/img/badges/silver.svg","placeholder":"/img/badges/silver.svg"}}],"affiliations":[]},"description":"{\"blocks\":[{\"key\":\"ddu7b\",\"text\":\"Lyso-IP is a method that allows for the isolation of lysosomes for proteomics and metabolomics (dx.doi.org/10.17504/protocols.io.bybjpskn; dx.doi.org/10.17504/protocols.io.bx9hpr36). We have developed an analogous approach for purification of early/sorting endosomes (Endo-IP). In addition, we have found that endolysosomal purification via Lyso-IP and Endo-IP can be coupled to a quantitative proteomics workflow to obtain snapshots of Amyloid Precursor Protein (APP) processing to its Aβ products (Park et al. 2022).  Here, we describe methods for cell line construction and maintenance of 293 cells with TMEM192-3xHA and 3xFLAG-EEA1, which are used for lysosome and endosome purification, respectively.  of patient mutations to APP promotes processing. Cells with endogenously-tagged TMEM192 and stably expressing FLAG-EEA1 are referred to as 293EL cells, for Endo-IP and Lyso-IP. These cells were also prepared in a form that has a deletion of the APP gene (293EL APP-/-) and the same cells reconstituted with a lentivirus stably expressing a patient mutant form (APPSw;T700N) which promotes APP processing and allows functional analysis of APP processing.\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[{\"style\":\"sup\",\"offset\":849,\"length\":2},{\"style\":\"sup\",\"offset\":965,\"length\":3},{\"style\":\"sup\",\"offset\":971,\"length\":3},{\"style\":\"sup\",\"offset\":1071,\"length\":8},{\"style\":\"bold\",\"offset\":863,\"length\":1},{\"style\":\"bold\",\"offset\":875,\"length\":1}],\"entityRanges\":[{\"key\":0,\"offset\":96,\"length\":41},{\"key\":1,\"offset\":139,\"length\":41}],\"data\":{}}],\"entityMap\":{\"0\":{\"type\":\"link\",\"mutability\":\"\",\"data\":{\"guid\":\"D014BA66248A11ECA02C0A58A9FEAC02\",\"url\":\"https://dx.doi.org/10.17504/protocols.io.bybjpskn\"}},\"1\":{\"type\":\"link\",\"mutability\":\"\",\"data\":{\"guid\":\"E10D25F7248A11ECA02C0A58A9FEAC02\",\"url\":\"https://dx.doi.org/10.17504/protocols.io.bx9hpr36\"}}}}","disclaimer":"{\"blocks\":[{\"key\":\"ddc39\",\"text\":\"DISCLAIMER – FOR INFORMATIONAL PURPOSES ONLY; USE AT YOUR OWN RISK\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":[]},{\"key\":\"d33ir\",\"text\":\"\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":[]},{\"key\":\"9sarv\",\"text\":\"The protocol content here is for informational purposes only and does not constitute legal, medical, clinical, or safety advice, or otherwise; content added to protocols.io is not peer reviewed and may not have undergone a formal approval of any kind. Information presented in this protocol should not substitute for independent professional judgment, advice, diagnosis, or treatment. Any action you take or refrain from taking using or relying upon the information presented here is strictly at your own risk. You agree that neither the Company nor any of the authors, contributors, administrators, or anyone else associated with protocols.io, can be held responsible for your use of the information contained in or linked to this protocol or any of our Sites/Apps and Services.\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[{\"key\":0,\"offset\":160,\"length\":12},{\"key\":1,\"offset\":631,\"length\":12}],\"data\":[]}],\"entityMap\":{\"0\":{\"type\":\"link\",\"mutability\":\"\",\"data\":{\"guid\":\"500836451F9411ECB7470A58A9FEAC02\",\"url\":\"http://protocols.io\"}},\"1\":{\"type\":\"link\",\"mutability\":\"\",\"data\":{\"guid\":\"500836961F9411ECB7470A58A9FEAC02\",\"url\":\"http://protocols.io\"}}}}","document":"","documents":[],"doi":"dx.doi.org/10.17504/protocols.io.4r3l24kxxg1y/v2","doi_status":2,"fork_id":null,"fork_info":null,"forks":[],"funders":[],"groups":[],"guid":"39B6E426BEF94A5F89ADDD562E222AA5","guidelines":"","has_references":false,"has_versions":true,"id":59915,"image":{"source":"https://www.protocols.io/img/default_protocol.png","webp_source":null,"placeholder":"https://www.protocols.io/img/default_protocol.png","webp_placeholder":null},"image_attribution":"","in_trash":false,"is_bookmarked":false,"is_contact_suspended":false,"is_content_confidential":false,"is_content_warning":false,"is_in_transfer":false,"is_owner":true,"is_retracted":false,"is_shared_directly":false,"is_subprotocol":null,"is_unlisted":false,"item_id":894185,"journal":null,"journals":[],"keywords":"ASAPCRN","last_modified":1648843010,"link":"","location":null,"manuscript_citation":"","materials":[],"materials_text":"{\"blocks\":[{\"key\":\"5r88q\",\"text\":\" \",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":[]},{\"key\":\"4md9g\",\"text\":\"  \",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":[]},{\"key\":\"329p0\",\"text\":\"     REAGENT or RESOURCE      SOURCE      IDENTIFIER        Chemicals, peptides, and recombinant proteins        Puromycin      Sigma-Aldrich      P9620        G418 (Geneticin)      Invivogen      ant-gn-2        Dulbecco’s MEM (DMEM), high glucose, pyruvate       GIBCO / Invitrogen       11995        Experimental models: Cell lines                      293T cells      ATCC      CRL-3216        293 cells      ATCC      CRL-1573        293L: TMEM192-3xHA      This study               293L-APP-/-: TMEM192-3xHA; APP-/-      This study               293EL-APP-/-: TMEM192-3xHA; APP-/-; FLAG-EEA1      This study               293EL-APP*: TMEM192-3xHA; APP-/-; FLAG-EEA1; APPSw;T700N      This study               Recombinant DNA                      pSMART TMEM192-3xHA   (targeting vector for genomic tagging)      35      Addgene #        pHAGE-FLAG-EEA1      This study      Deposited in   Addgene        pHAGE-FLAG-RAB11      This study      Deposited in   Addgene        pPHAGE-FLAG-TFR1      This study      Deposited in   Addgene        pPHAGE-FLAG-RAB5A      This study      Deposited in   Addgene        pX459-gRNA-APP   (for making APP deletion by CRISPR/Cas9)      This study      Deposited in   Addgene        pENTR221-APP751       DNA Resource Core, Harvard Medical   School      HsCD00431993         pHAGE-APPSw;T719N      This study      Deposited in   Addgene   \",\"type\":\"atomic\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[{\"key\":0,\"offset\":0,\"length\":1380}],\"data\":[]},{\"key\":\"fd3d1\",\"text\":\" \\n\\n\\n\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":[]},{\"key\":\"di7or\",\"text\":\" \",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":[]}],\"entityMap\":{\"0\":{\"type\":\"tables\",\"mutability\":\"\",\"data\":{\"cellsMeta\":{\"0_0\":\"\",\"0_1\":\"\",\"0_2\":\"\",\"10_0\":\"\",\"10_1\":\"\",\"10_2\":\"\",\"11_0\":\"\",\"11_1\":\"\",\"11_2\":\"\",\"12_0\":\"\",\"12_1\":\"\",\"12_2\":\"\",\"13_0\":\"\",\"13_1\":\"\",\"13_2\":\"\",\"14_0\":\"\",\"14_1\":\"\",\"14_2\":\"\",\"15_0\":\"\",\"15_1\":\"\",\"15_2\":\"\",\"16_0\":\"\",\"16_1\":\"\",\"16_2\":\"\",\"17_0\":\"\",\"17_1\":\"\",\"17_2\":\"\",\"18_0\":\"\",\"18_1\":\"\",\"18_2\":\"\",\"19_0\":\"\",\"19_1\":\"\",\"19_2\":\"\",\"1_0\":\"\",\"20_0\":\"\",\"20_1\":\"\",\"20_2\":\"\",\"2_0\":\"\",\"2_1\":\"\",\"2_2\":\"\",\"3_0\":\"\",\"3_1\":\"\",\"3_2\":\"\",\"4_0\":\"\",\"4_1\":\"\",\"4_2\":\"\",\"5_0\":\"\",\"5_1\":\"\",\"5_2\":\"\",\"6_0\":\"\",\"6_1\":\"\",\"6_2\":\"\",\"7_0\":\"\",\"7_1\":\"\",\"7_2\":\"\",\"8_0\":\"\",\"8_1\":\"\",\"8_2\":\"\",\"9_0\":\"\",\"9_1\":\"\",\"9_2\":\"\"},\"colTitles\":[\"\",\"\",\"\"],\"colWidths\":[200,120,106],\"data\":[[\"  \\u003cb\\u003eREAGENT or RESOURCE\\u003c/b\\u003e  \",\"  \\u003cb\\u003eSOURCE\\u003c/b\\u003e  \",\"  \\u003cb\\u003eIDENTIFIER\\u003c/b\\u003e  \"],[\"  \\u003cb\\u003eChemicals, peptides, and recombinant proteins\\u003c/b\\u003e  \",\"\",\"\"],[\"  Puromycin  \",\"  Sigma-Aldrich  \",\"  P9620  \"],[\"  G418 (Geneticin)  \",\"  Invivogen  \",\"  ant-gn-2  \"],[\"  Dulbecco’s MEM (DMEM), high glucose, pyruvate   \",\"  GIBCO / Invitrogen   \",\"  11995  \"],[\"  \\u003cb\\u003eExperimental models: Cell lines\\u003c/b\\u003e  \",\"     \",\"     \"],[\"  293T cells  \",\"  ATCC  \",\"  CRL-3216  \"],[\"  293 cells  \",\"  ATCC  \",\"  CRL-1573  \"],[\"  293L: TMEM192-3xHA  \",\"  This study  \",\"     \"],[\"  293L-APP-/-: TMEM192-3xHA; APP-/-  \",\"  This study  \",\"     \"],[\"  293EL-APP-/-: TMEM192-3xHA; APP-/-; FLAG-EEA1  \",\"  This study  \",\"     \"],[\"  293EL-APP*: TMEM192-3xHA; APP-/-; FLAG-EEA1; APPSw;T700N  \",\"  This study  \",\"     \"],[\"  \\u003cb\\u003eRecombinant DNA\\u003c/b\\u003e  \",\"     \",\"     \"],[\"  pSMART TMEM192-3xHA\\n  (targeting vector for genomic tagging)  \",\"  35  \",\"  Addgene #175777\"],[\"  pHAGE-FLAG-EEA1  \",\"  This study  \",\"Addgene #176491\"],[\"  pHAGE-FLAG-RAB11A\",\"  This study  \",\"Addgene #176489\"],[\"  pPHAGE-FLAG-TFR1  \",\"  This study  \",\"Addgene #176490\"],[\"  pPHAGE-FLAG-RAB5A  \",\"  This study  \",\"Addgene #176488\"],[\"  pX459-gRNA-APP\\n  (for making APP deletion by CRISPR/Cas9)  \",\"  This study  \",\"Addgene #176487\"],[\"  pENTR221-APP751   \",\"  DNA Resource Core, Harvard Medical\\n  School  \",\"  HsCD00431993   \"],[\"  pHAGE-APPSw;T700N  \",\"  This study  \",\"  Deposited in\\n  Addgene  \"]],\"guid\":\"919C22861F9811ECB7470A58A9FEAC02\",\"isJexcelDataFormat\":true,\"legend\":\"\",\"mergeCells\":[],\"printData\":[[\"  \\u003cb\\u003eREAGENT or RESOURCE\\u003c/b\\u003e  \",\"  \\u003cb\\u003eSOURCE\\u003c/b\\u003e  \",\"  \\u003cb\\u003eIDENTIFIER\\u003c/b\\u003e  \"],[\"  \\u003cb\\u003eChemicals, peptides, and recombinant proteins\\u003c/b\\u003e  \",\"\",\"\"],[\"  Puromycin  \",\"  Sigma-Aldrich  \",\"  P9620  \"],[\"  G418 (Geneticin)  \",\"  Invivogen  \",\"  ant-gn-2  \"],[\"  Dulbecco’s MEM (DMEM), high glucose, pyruvate   \",\"  GIBCO / Invitrogen   \",\"  11995  \"],[\"  \\u003cb\\u003eExperimental models: Cell lines\\u003c/b\\u003e  \",\"     \",\"     \"],[\"  293T cells  \",\"  ATCC  \",\"  CRL-3216  \"],[\"  293 cells  \",\"  ATCC  \",\"  CRL-1573  \"],[\"  293L: TMEM192-3xHA  \",\"  This study  \",\"     \"],[\"  293L-APP-/-: TMEM192-3xHA; APP-/-  \",\"  This study  \",\"     \"],[\"  293EL-APP-/-: TMEM192-3xHA; APP-/-; FLAG-EEA1  \",\"  This study  \",\"     \"],[\"  293EL-APP*: TMEM192-3xHA; APP-/-; FLAG-EEA1; APPSw;T700N  \",\"  This study  \",\"     \"],[\"  \\u003cb\\u003eRecombinant DNA\\u003c/b\\u003e  \",\"     \",\"     \"],[\"  pSMART TMEM192-3xHA\\n  (targeting vector for genomic tagging)  \",\"  35  \",\"  Addgene #175777\"],[\"  pHAGE-FLAG-EEA1  \",\"  This study  \",\"Addgene #176491\"],[\"  pHAGE-FLAG-RAB11A\",\"  This study  \",\"Addgene #176489\"],[\"  pPHAGE-FLAG-TFR1  \",\"  This study  \",\"Addgene #176490\"],[\"  pPHAGE-FLAG-RAB5A  \",\"  This study  \",\"Addgene #176488\"],[\"  pX459-gRNA-APP\\n  (for making APP deletion by CRISPR/Cas9)  \",\"  This study  \",\"Addgene #176487\"],[\"  pENTR221-APP751   \",\"  DNA Resource Core, Harvard Medical\\n  School  \",\"  HsCD00431993   \"],[\"  pHAGE-APPSw;T700N  \",\"  This study  \",\"  Deposited in\\n  Addgene  \"]],\"rowHeights\":[23,23,23,23,23,23,23,23,23,23,23,23,23,23,23,23,23,23,23,23,23]}}}}","ownership_history":null,"parent_collections":[],"parent_protocols":[],"peer_reviewed":false,"public":true,"public_fork_note":"","published_on":1648843010,"references":[],"related_equipments":[],"retraction_reason":null,"shared_access_id":16,"show_comparison":false,"sign_info":null,"state_version_id":129,"stats":{"is_voted":false,"number_of_views":102,"number_of_steps":10,"number_of_bookmarks":0,"number_of_comments":0,"number_of_bookmarked_comments":0,"number_of_steps_comments":0,"number_of_protocol_comments":0,"number_of_exports":0,"number_of_runs":0,"number_of_votes":0,"number_of_reagents":0,"number_of_equipments":0,"number_of_collections":0,"number_of_forks":{"private":0,"public":0},"number_of_accessible_forks":0},"status":{"id":1,"info":"We use this protocol and it’s working"},"steps":[{"id":1371278,"guid":"F2F2420D75BE400784BC191510C0F8DB","previous_id":null,"previous_guid":null,"section":"\u003cp\u003eCell line maintenance\u003c/p\u003e","section_color":"#A492FF","section_duration":0,"is_substep":false,"step":"{\"blocks\":[{\"key\":\"e2v81\",\"text\":\"Maintain 293 cells in Dulbecco’ Modifies Eagles Medium (DMEM) with 10% fetal bovine serum and optional 1% penicillin-streptomycin. Additionally, grow 293EL cells in 1.2 µg/ml puromycin and 200 µg/ml G418 to maintain selection for 3xFLAG-EEA1 and TMEM192-3XHA, respectively.\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[{\"style\":\"sup\",\"offset\":153,\"length\":2}],\"entityRanges\":[],\"data\":{}}],\"entityMap\":{}}","data":null,"protocol_id":59915,"case_id":0,"critical_ids":"","duration":0,"original_id":1257896,"number":"1","cases":[],"critical":null},{"id":1371279,"guid":"5D1E3F59CFA049BD89BFAB25CDA13ECD","previous_id":1371278,"previous_guid":"F2F2420D75BE400784BC191510C0F8DB","section":"\u003cp\u003eEndogenous tagging of TMEM192 with 3xHA\u003c/p\u003e","section_color":"#94EBFF","section_duration":0,"is_substep":false,"step":"{\"blocks\":[{\"key\":\"a4m5v\",\"text\":\"For endogenous tagging of TMEM192 with 3xHA, co-transfect 293 cells with pX459 containing a gRNA (5’-AGTAGAACGTGAGAGGCTCA) targeting adjacent to the translational termination sequence in TMEM192 and pSMART containing 5’ and 3’ homology arms for TMEM192 in which the termination codon is replaced by a 3xHA epitope sequence followed by a TAA stop codon (Addgene #175777).\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":[]}],\"entityMap\":{}}","data":null,"protocol_id":59915,"case_id":0,"critical_ids":"","duration":0,"original_id":1257897,"number":"2","cases":[],"critical":null},{"id":1371280,"guid":"E1ACD18E7AF24BA3918DED5E059FD248","previous_id":1371279,"previous_guid":"5D1E3F59CFA049BD89BFAB25CDA13ECD","section":"\u003cp\u003eEndogenous tagging of TMEM192 with 3xHA\u003c/p\u003e","section_color":"#94EBFF","section_duration":0,"is_substep":false,"step":"{\"blocks\":[{\"key\":\"bb21q\",\"text\":\"Identify homozygously targeted clones by immunoblotting cell extracts with α-HA and α-TMEM192. These are referred to as 293L cells for Lyso-IP.\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[{\"style\":\"sup\",\"offset\":123,\"length\":2}],\"entityRanges\":[],\"data\":[]}],\"entityMap\":{}}","data":null,"protocol_id":59915,"case_id":0,"critical_ids":"","duration":0,"original_id":1257898,"number":"3","cases":[],"critical":null},{"id":1371281,"guid":"45AD6E31E7B6435A88917AD02F8B8FC9","previous_id":1371280,"previous_guid":"E1ACD18E7AF24BA3918DED5E059FD248","section":"\u003cp\u003eStable expression of 3xFLAG-EEA1\u003c/p\u003e","section_color":"#84CE84","section_duration":0,"is_substep":false,"step":"{\"blocks\":[{\"key\":\"7cevg\",\"text\":\"Generate puromycin-resistant pHAGE lentiviral vectors expressing EEA1 by recombining open reading frames in pENTR vectors into a pHAGE-N-3xFLAG vector.\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":[]}],\"entityMap\":{}}","data":null,"protocol_id":59915,"case_id":0,"critical_ids":"","duration":0,"original_id":1257899,"number":"4","cases":[],"critical":null},{"id":1371282,"guid":"24DD294782094790865579BEB197353E","previous_id":1371281,"previous_guid":"45AD6E31E7B6435A88917AD02F8B8FC9","section":"\u003cp\u003eStable expression of 3xFLAG-EEA1\u003c/p\u003e","section_color":"#84CE84","section_duration":0,"is_substep":false,"step":"{\"blocks\":[{\"key\":\"k6bd\",\"text\":\"Infect 293L cells with viral supernatants derived from transfection of 293T cells with pHAGE-3xFLAG-EEA1 vector (Addgene #176491) and appropriate packaging and envelope vectors. Select for viral integration with puromycin (1.2 µg/ml). Select a monoclonal population. These are referred to as 293EL cells for Endo-IP and Lyso-IP.\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[{\"style\":\"sup\",\"offset\":10,\"length\":2},{\"style\":\"sup\",\"offset\":295,\"length\":3}],\"entityRanges\":[],\"data\":{}}],\"entityMap\":{}}","data":null,"protocol_id":59915,"case_id":0,"critical_ids":"","duration":0,"original_id":1257901,"number":"5","cases":[],"critical":null},{"id":1371283,"guid":"C77E2E89D5C4482DA6F550588D944A90","previous_id":1371282,"previous_guid":"24DD294782094790865579BEB197353E","section":"\u003cp\u003eAPP knock-out\u003c/p\u003e","section_color":"#FFED92","section_duration":0,"is_substep":false,"step":"{\"blocks\":[{\"key\":\"6urnc\",\"text\":\"For APP knock-out, phosphorylate and anneal oligonucleotides (Top: 5’- CACCGGCGGAATTGACAAGTTCCGA, Bottom: 5’-AAACTCGGAACTTGTCAATTCCGCC), and clone into a pX459 vector. \",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":[]}],\"entityMap\":{}}","data":null,"protocol_id":59915,"case_id":0,"critical_ids":"","duration":0,"original_id":1260366,"number":"6","cases":[],"critical":null},{"id":1371284,"guid":"A8BD5FEB3FE14ECD9DC02E291AC3202A","previous_id":1371283,"previous_guid":"C77E2E89D5C4482DA6F550588D944A90","section":"\u003cp\u003eAPP knock-out\u003c/p\u003e","section_color":"#FFED92","section_duration":0,"is_substep":false,"step":"{\"blocks\":[{\"key\":\"e0ppp\",\"text\":\"Transfect 293EL cells with the pX459-gRNA-APP plasmid (Addgene #176487) with Lipofectamine 3000, and select with 1.2 µg/mL of puromycin. Select monoclonal population, and confirm APP deletion by Western blotting.\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[{\"style\":\"sup\",\"offset\":13,\"length\":2}],\"entityRanges\":[],\"data\":{}}],\"entityMap\":{}}","data":null,"protocol_id":59915,"case_id":0,"critical_ids":"","duration":0,"original_id":1260367,"number":"7","cases":[],"critical":null},{"id":1371285,"guid":"F30A584B152F444F94B7EBA76BB3D620","previous_id":1371284,"previous_guid":"A8BD5FEB3FE14ECD9DC02E291AC3202A","section":"\u003cp\u003eStable expression of APP\u003csup\u003esw,T700N\u003c/sup\u003e\u003c/p\u003e","section_color":"#EA9F6C","section_duration":0,"is_substep":false,"step":"{\"blocks\":[{\"key\":\"2964o\",\"text\":\"To create an APP (isoform 751) open reading frame: PCR amplify pENTR-APP751 (open, no stop codon) to replace W752 with a stop codon using forward primer (5'-GCAGAACTAGATCCACCCAGCTTTCTTG) and reverse primer (5'-GGGTGGATCTAGTTCTGCATCTGCTCAAAG).\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":[]}],\"entityMap\":{}}","data":null,"protocol_id":59915,"case_id":0,"critical_ids":"","duration":0,"original_id":1257902,"number":"8","cases":[],"critical":null},{"id":1371286,"guid":"4BC8C16E14854185B302B7C61DBE1C91","previous_id":1371285,"previous_guid":"F30A584B152F444F94B7EBA76BB3D620","section":"\u003cp\u003eStable expression of APP\u003csup\u003esw,T700N\u003c/sup\u003e\u003c/p\u003e","section_color":"#EA9F6C","section_duration":0,"is_substep":false,"step":"{\"blocks\":[{\"key\":\"5rk28\",\"text\":\"Use two rounds of PCR to generate pENTR-APPSw,T700N using the following kits and primers: Sw (K651M/N652L): QuickChange II mutagenesis kit; Forward: 5'-tcggaattctgcatccagattcacttcagagatctcctccg; Reverse: 5'-cggaggagatctctgaagtgaatctggatgcagaattccga; T700N: Q5 mutagenesis kit; Forward: 5'- ATCGTCATCAACTTGGTGATG; Reverse: 5'- CACTGTCGCTATGACAAC. Transfer the APPSw,T700N open reading frame in pENTR to Gateway destination vector pHAGE-C-HA-FLAG-puro using Clonase to yield pHAGE-APPSw,T700N-puro.\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[{\"style\":\"sup\",\"offset\":43,\"length\":8},{\"style\":\"sup\",\"offset\":362,\"length\":8},{\"style\":\"sup\",\"offset\":482,\"length\":8}],\"entityRanges\":[],\"data\":{}},{\"key\":\"3hu8c\",\"text\":\"\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"aopu5\",\"text\":\"Note: the stop codon in the APP open reading frame blocks translation into the HA-FLAG tag in this vector.\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}}],\"entityMap\":{}}","data":null,"protocol_id":59915,"case_id":0,"critical_ids":"","duration":0,"original_id":1257903,"number":"9","cases":[],"critical":null},{"id":1371287,"guid":"D5A080B3D2E44F9FA4257875B2B691C1","previous_id":1371286,"previous_guid":"4BC8C16E14854185B302B7C61DBE1C91","section":"\u003cp\u003eStable expression of APP\u003csup\u003esw,T700N\u003c/sup\u003e\u003c/p\u003e","section_color":"#EA9F6C","section_duration":0,"is_substep":false,"step":"{\"blocks\":[{\"key\":\"7iucg\",\"text\":\"Prepare a stable cell line by lentiviral transduction of APPSw,T700N to 293EL APP-/- cells followed by monoclonal selection.\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[{\"style\":\"sup\",\"offset\":60,\"length\":9},{\"style\":\"sup\",\"offset\":75,\"length\":3},{\"style\":\"sup\",\"offset\":81,\"length\":3}],\"entityRanges\":[],\"data\":{}}],\"entityMap\":{}}","data":null,"protocol_id":59915,"case_id":0,"critical_ids":"","duration":0,"original_id":1260368,"number":"10","cases":[],"critical":null}],"template_id":4,"title":"Cell line construction and maintenance for Lyso-IP and Endo-IP analysis of amyloid precursor protein processing, version 2","title_html":"\u003cp\u003eCell line construction and maintenance for Lyso-IP and Endo-IP analysis of amyloid precursor protein processing, version 2\u003c/p\u003e","type_id":1,"units":[{"id":1,"type_id":3,"name":"µL","can_manage":0},{"id":2,"type_id":3,"name":"mL","can_manage":0},{"id":3,"type_id":3,"name":"L","can_manage":0},{"id":4,"type_id":3,"name":"µg","can_manage":0},{"id":5,"type_id":3,"name":"mg","can_manage":0},{"id":6,"type_id":3,"name":"g","can_manage":0},{"id":7,"type_id":3,"name":"kg","can_manage":0},{"id":8,"type_id":3,"name":"ng","can_manage":0},{"id":9,"type_id":3,"name":"Hz","can_manage":0},{"id":10,"type_id":24,"name":"°C","can_manage":0},{"id":11,"type_id":24,"name":"°К","can_manage":0},{"id":12,"type_id":24,"name":"°F","can_manage":0},{"id":13,"type_id":25,"name":"Mass Percent","can_manage":0},{"id":14,"type_id":25,"name":"% volume","can_manage":0},{"id":15,"type_id":25,"name":"Mass / % volume","can_manage":0},{"id":16,"type_id":25,"name":"Parts per Million (PPM)","can_manage":0},{"id":17,"type_id":25,"name":"Parts per Billion (PPB)","can_manage":0},{"id":18,"type_id":25,"name":"Parts per Trillion (PPT)","can_manage":0},{"id":19,"type_id":25,"name":"Mole Fraction","can_manage":0},{"id":20,"type_id":25,"name":"Mole Percent","can_manage":0},{"id":21,"type_id":25,"name":"Molarity (M)","can_manage":0},{"id":22,"type_id":25,"name":"Molarity (m)","can_manage":0},{"id":23,"type_id":25,"name":"Genome copies per ml","can_manage":0},{"id":24,"type_id":3,"name":"μV","can_manage":0},{"id":25,"type_id":3,"name":"ms","can_manage":0},{"id":26,"type_id":3,"name":"pg","can_manage":0},{"id":27,"type_id":25,"name":"Molarity dilutions","can_manage":0},{"id":28,"type_id":25,"name":"millimolar (mM)","can_manage":0},{"id":29,"type_id":25,"name":"micromolar (µM)","can_manage":0},{"id":30,"type_id":25,"name":"nanomolar (nM)","can_manage":0},{"id":31,"type_id":25,"name":"picomolar (pM)","can_manage":0},{"id":32,"type_id":24,"name":"Room temperature","can_manage":0},{"id":33,"type_id":30,"name":"rpm","can_manage":0},{"id":34,"type_id":30,"name":"x g","can_manage":0},{"id":165,"type_id":24,"name":"On ice","can_manage":0},{"id":200,"type_id":32,"name":"cm","can_manage":0},{"id":201,"type_id":32,"name":"mm","can_manage":0},{"id":202,"type_id":32,"name":"µm","can_manage":0},{"id":203,"type_id":32,"name":"nm","can_manage":0},{"id":204,"type_id":25,"name":"mg/mL","can_manage":0},{"id":205,"type_id":25,"name":"µg/µL","can_manage":0},{"id":206,"type_id":25,"name":"% (v/v)","can_manage":0},{"id":1324,"type_id":30,"name":"rcf","can_manage":0},{"id":1359,"type_id":35,"name":"Bar","can_manage":0},{"id":1360,"type_id":35,"name":"Pa","can_manage":0}],"uri":"cell-line-construction-and-maintenance-for-lyso-ip-b6rjrd4n","url":"https://www.protocols.io/view/cell-line-construction-and-maintenance-for-lyso-ip-b6rjrd4n","version_class":53567,"version_data":{"id":1,"code":"b6rjrd4n","version_class":53567,"parent_id":53567,"parent_uri":"cell-line-construction-and-maintenance-for-lyso-ip-byi7puhn","is_same_owner":true,"is_parent_public":false,"has_pending_merge_request":false,"has_approved_merge_request":true,"merge_request":{"id":1148,"creator":{"name":"Frances Hundley","affiliation":null,"affiliation_url":null,"username":"frances-hundley","link":"","image":{"source":"/img/avatars/010.png","placeholder":"/img/avatars/010.png","webp_source":""}},"created_on":1648230937,"can_manage":true}},"version_id":1,"version_uri":"cell-line-construction-and-maintenance-for-lyso-ip-4r3l24kxxg1y/v2","versions":[{"id":53567,"title":"Cell line construction and maintenance for Lyso-IP and Endo-IP analysis of amyloid precursor protein processing","title_html":"\u003cp\u003eCell line construction and maintenance for Lyso-IP and Endo-IP analysis of amyloid precursor protein processing\u003c/p\u003e","image":{"source":"https://www.protocols.io/img/default_protocol.png","webp_source":null,"placeholder":"https://www.protocols.io/img/default_protocol.png","webp_placeholder":null},"doi":"dx.doi.org/10.17504/protocols.io.byi7puhn","uri":"cell-line-construction-and-maintenance-for-lyso-ip-byi7puhn","published_on":1633294227,"modified_on":1633294090,"version_class":53567,"version_id":0,"version_code":"byi7puhn","version_uri":"cell-line-construction-and-maintenance-for-lyso-ip-4r3l24kxxg1y/v1","created_on":1632747803,"categories":null,"creator":{"name":"Frances Hundley","affiliation":null,"affiliation_url":null,"username":"frances-hundley","link":"","image":{"source":"/img/avatars/010.png","placeholder":"/img/avatars/010.png","webp_source":""}},"stats":{"number_of_comments":0,"last_comment_time":0}},{"id":59915,"title":"Cell line construction and maintenance for Lyso-IP and Endo-IP analysis of amyloid precursor protein processing, version 2","title_html":"\u003cp\u003eCell line construction and maintenance for Lyso-IP and Endo-IP analysis of amyloid precursor protein processing, version 2\u003c/p\u003e","image":{"source":"https://www.protocols.io/img/default_protocol.png","webp_source":null,"placeholder":"https://www.protocols.io/img/default_protocol.png","webp_placeholder":null},"doi":"dx.doi.org/10.17504/protocols.io.4r3l24kxxg1y/v2","uri":"cell-line-construction-and-maintenance-for-lyso-ip-b6rjrd4n","published_on":1648759495,"modified_on":1648843010,"version_class":53567,"version_id":1,"version_code":"b6rjrd4n","version_uri":"cell-line-construction-and-maintenance-for-lyso-ip-4r3l24kxxg1y/v2","created_on":1648229936,"categories":null,"creator":{"name":"Frances Hundley","affiliation":null,"affiliation_url":null,"username":"frances-hundley","link":"","image":{"source":"/img/avatars/010.png","placeholder":"/img/avatars/010.png","webp_source":""}},"stats":{"number_of_comments":0,"last_comment_time":0}}],"warning":""}